Michael Bodmer

Summary

Affiliation: University Hospital
Country: Switzerland

Publications

  1. doi request reprint [Poisoning with antidepressants]
    Michael Bodmer
    Notfallstation und Abteilung für Klinische Pharmakologie und Toxikologie, Kantonsspital Basel, Basel
    Ther Umsch 66:335-41. 2009
  2. doi request reprint Metformin does not alter the risk of lung cancer: a case-control analysis
    Michael Bodmer
    Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Switzerland
    Lung Cancer 78:133-7. 2012
  3. ncbi request reprint Lichenoid eruption associated with the use of nebivolol
    Michael Bodmer
    Clinical Pharmacology and Toxicology, University Hospital, Basel, Switzerland
    Ann Pharmacother 40:1688-90. 2006
  4. ncbi request reprint [Intoxication with an unknown sedative substance]
    M Bodmer
    Abteilung für Klinische Pharmakologie und Toxikologie, Universitatsspital Basel, Basel
    Praxis (Bern 1994) 97:820-5. 2008
  5. doi request reprint Pharmacokinetics and pharmacodynamics of quetiapine in a patient with a massive overdose
    Michael Bodmer
    Department of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland
    Ther Drug Monit 30:553-6. 2008
  6. doi request reprint Safety of non-therapeutic levetiracetam ingestions--a poison center based study
    Michael Bodmer
    Rocky Mountain Poison and Drug Center, Denver, CO, USA
    Pharmacoepidemiol Drug Saf 20:366-9. 2011
  7. ncbi request reprint Focal segmental glomerulosclerosis associated with long-term treatment with zoledronate in a myeloma patient
    Michael Bodmer
    Department of Clinical Pharmacology and Toxicology, University Hospital Basel, Switzerland
    Nephrol Dial Transplant 22:2366-70. 2007
  8. pmc Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis
    Michael Bodmer
    Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland
    Diabetes Care 31:2086-91. 2008
  9. doi request reprint Seizures in patients with Alzheimer's disease or vascular dementia: a population-based nested case-control analysis
    Patrick Imfeld
    Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland
    Epilepsia 54:700-7. 2013
  10. doi request reprint Use of antidiabetic agents and the risk of pancreatic cancer: a case-control analysis
    Michael Bodmer
    Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland
    Am J Gastroenterol 107:620-6. 2012

Collaborators

Detail Information

Publications40

  1. doi request reprint [Poisoning with antidepressants]
    Michael Bodmer
    Notfallstation und Abteilung für Klinische Pharmakologie und Toxikologie, Kantonsspital Basel, Basel
    Ther Umsch 66:335-41. 2009
    ..The selective serotonin reuptake inhibitors (SSRI) and the atypical antidepressants are far less toxic than tricyclics. They may lead to serotonin toxicity (serotonin syndrome)...
  2. doi request reprint Metformin does not alter the risk of lung cancer: a case-control analysis
    Michael Bodmer
    Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Switzerland
    Lung Cancer 78:133-7. 2012
    ..Metformin use has been linked to a decreased cancer risk. We explored the association between use of metformin or other antidiabetic drugs and the risk of lung cancer...
  3. ncbi request reprint Lichenoid eruption associated with the use of nebivolol
    Michael Bodmer
    Clinical Pharmacology and Toxicology, University Hospital, Basel, Switzerland
    Ann Pharmacother 40:1688-90. 2006
    ..To report a case of lichenoid drug eruption (LDE) after starting antihypertensive treatment with nebivolol, a cardioselective beta-blocker...
  4. ncbi request reprint [Intoxication with an unknown sedative substance]
    M Bodmer
    Abteilung für Klinische Pharmakologie und Toxikologie, Universitatsspital Basel, Basel
    Praxis (Bern 1994) 97:820-5. 2008
    ..Phenobarbital was detected in the blood. Decontamination procedures and therapy in patients with phenobarbital intoxication are delineated and discussed...
  5. doi request reprint Pharmacokinetics and pharmacodynamics of quetiapine in a patient with a massive overdose
    Michael Bodmer
    Department of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland
    Ther Drug Monit 30:553-6. 2008
    ..The final elimination of the drug from the body occurred after approximately 34 hours at much slower rate, most probably reflecting redistribution from tissues into blood and consecutive hepatic clearance of the drug...
  6. doi request reprint Safety of non-therapeutic levetiracetam ingestions--a poison center based study
    Michael Bodmer
    Rocky Mountain Poison and Drug Center, Denver, CO, USA
    Pharmacoepidemiol Drug Saf 20:366-9. 2011
    ..Very limited data is available regarding the safety of levetiracetam in cases of unintentional or intentional ingestions...
  7. ncbi request reprint Focal segmental glomerulosclerosis associated with long-term treatment with zoledronate in a myeloma patient
    Michael Bodmer
    Department of Clinical Pharmacology and Toxicology, University Hospital Basel, Switzerland
    Nephrol Dial Transplant 22:2366-70. 2007
  8. pmc Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis
    Michael Bodmer
    Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland
    Diabetes Care 31:2086-91. 2008
    ..Hypoglycemia is a major concern using sulfonylureas. The aim of this study was to compare the risk of lactic acidosis and hypoglycemia among patients with type 2 diabetes using oral antidiabetes drugs...
  9. doi request reprint Seizures in patients with Alzheimer's disease or vascular dementia: a population-based nested case-control analysis
    Patrick Imfeld
    Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland
    Epilepsia 54:700-7. 2013
    ..The aim of this study was to assess incidence rates (IRs) of seizures/epilepsy in patients with AD, VD, or without dementia, and to identify potential risk factors of seizures or epilepsy...
  10. doi request reprint Use of antidiabetic agents and the risk of pancreatic cancer: a case-control analysis
    Michael Bodmer
    Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland
    Am J Gastroenterol 107:620-6. 2012
    ..The objective of this study was to explore the association between use of metformin or other antidiabetic drugs, diabetes, and the risk of pancreatic cancer...
  11. pmc Pharmacokinetics of intravenous and oral midazolam in plasma and saliva in humans: usefulness of saliva as matrix for CYP3A phenotyping
    Bettina Link
    Division of Clinical Pharmacology and Toxicology and Department of Research, University Hospital, Basel, Switzerland
    Br J Clin Pharmacol 66:473-84. 2008
    ..To compare midazolam kinetics between plasma and saliva and to find out whether saliva is suitable for CYP3A phenotyping...
  12. pmc Long-term metformin use is associated with decreased risk of breast cancer
    Michael Bodmer
    Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland
    Diabetes Care 33:1304-8. 2010
    ..To evaluate whether use of oral hypoglycemic agents is associated with an altered breast cancer risk in women...
  13. doi request reprint Use of diuretics and risk of incident gout: a population-based case-control study
    Saskia Bruderer
    University of Basel and University Hospital Basel, Basel, Switzerland
    Arthritis Rheumatol 66:185-96. 2014
    ..We undertook this study to investigate the association between use of loop diuretics, thiazide or thiazide-like diuretics, and potassium-sparing agents and the risk of developing incident gout...
  14. doi request reprint Metformin and the risk of endometrial cancer: a case-control analysis
    Claudia Becker
    Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Switzerland
    Gynecol Oncol 129:565-9. 2013
    ..To explore the risk of endometrial cancer in relation to metformin and other antidiabetic drugs...
  15. doi request reprint Use of metformin and the risk of ovarian cancer: a case-control analysis
    Michael Bodmer
    Department of Pharmaceutical Sciences, University of Basel, Switzerland
    Gynecol Oncol 123:200-4. 2011
    ..To explore the association between use of metformin or other antidiabetic drugs and the risk of ovarian cancer...
  16. doi request reprint Risk of incident stroke in patients with Alzheimer disease or vascular dementia
    Patrick Imfeld
    Basel Pharmacoepidemiology Unit, University Hospital Basel, Switzerland
    Neurology 81:910-9. 2013
    ..To explore the risk of ischemic stroke, hemorrhagic stroke, or TIA in patients with Alzheimer disease (AD) or vascular dementia (VD)...
  17. doi request reprint Use of metformin is not associated with a decreased risk of colorectal cancer: a case-control analysis
    Michael Bodmer
    Basel Pharmacoepidemiology Unit, Hospital Pharmacy, University Hospital Basel, Spitalstrasse 26, CH 4031 Basel, Switzerland
    Cancer Epidemiol Biomarkers Prev 21:280-6. 2012
    ..To explore the association between use of metformin or other antidiabetic drugs and the risk of colorectal cancer...
  18. doi request reprint Statin use and risk of gallstone disease followed by cholecystectomy
    Michael Bodmer
    Division of Clinical Pharmacology and Toxicology, University Hospital, Basel, Switzerland
    JAMA 302:2001-7. 2009
    ..Statins decrease hepatic cholesterol biosynthesis and may therefore lower the risk of cholesterol gallstones by reducing the cholesterol concentration in the bile. Data on this association in humans are scarce...
  19. doi request reprint Risk of fractures with glitazones: a critical review of the evidence to date
    Michael Bodmer
    Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland
    Drug Saf 32:539-47. 2009
    ..As a consequence of these observations, clinicians should carefully assess the fracture risk in patients with type 2 diabetes before starting therapy with glitazones...
  20. doi request reprint Pharmacokinetics of midazolam and metabolites in a patient with refractory status epilepticus treated with extraordinary doses of midazolam
    Michael Bodmer
    Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland
    Ther Drug Monit 30:120-4. 2008
    ..Even in patients with hepatic CYP3A induction, the half-life of MDZ increases with high doses as a result of a rise in its volume of distribution, which is a consequence of an increase in the free fraction of MDZ...
  21. doi request reprint Diabetes mellitus and the risk of cholecystectomy
    Michael Bodmer
    Emergency Department, University Hospital Basel, Switzerland
    Dig Liver Dis 43:742-7. 2011
    ..Whether diabetes mellitus is associated with an increased risk of cholecystectomy remains controversial...
  22. pmc Drug-related emergency department visits by elderly patients presenting with non-specific complaints
    Christian H Nickel
    Department of Emergency Medicine, University Hospital Basel, Basel, Switzerland
    Scand J Trauma Resusc Emerg Med 21:15. 2013
    ....
  23. doi request reprint Comparison of the dissolution and pharmacokinetic profiles of two galenical formulations of the endothelin receptor antagonist macitentan
    Oliver Kummer
    Division of Clinical Pharmacology and Toxicology and Department of Biomedicine, University Hospital, CH 4031 Basel, Switzerland
    Eur J Pharm Sci 38:384-8. 2009
    ..We conclude that the absorption profile of the tablet differs from the capsule in peak but not in total exposure, which is not expected to be of clinical significance...
  24. doi request reprint Proton pump inhibitors and fracture risk: true effect or residual confounding?
    Michael Bodmer
    Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland
    Drug Saf 33:843-52. 2010
    ....
  25. doi request reprint Use of thiazolidinediones and fracture risk
    Christian Meier
    Division of Endocrinology, Diabetes, and Clinical Nutrition, University Hospital Basel, Hebelstrasse 2, CH 4031 Basel, Switzerland
    Arch Intern Med 168:820-5. 2008
    ..Thiazolidinediones may adversely affect the skeleton owing to decreased bone formation and accelerated bone loss...
  26. doi request reprint Metformin, other antidiabetic drugs, and risk of Alzheimer's disease: a population-based case-control study
    Patrick Imfeld
    Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland
    J Am Geriatr Soc 60:916-21. 2012
    ..To explore the risk of developing Alzheimer's disease (AD) in individuals with diabetes mellitus treated with metformin or other antidiabetic drugs...
  27. doi request reprint Pharmacokinetics and pharmacodynamics of sildenafil in a patient treated with human immunodeficiency virus protease inhibitors
    Yvonne Zysset Aschmann
    Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland
    Ther Drug Monit 30:130-4. 2008
    ..Patients treated concomitantly with protease inhibitors and sildenafil need close monitoring of plasma levels, pharmacodynamics, and toxicity of sildenafil in order to be treated optimally...
  28. ncbi request reprint [Drug-induced microscopic colitis]
    O Kummer
    Klinische Pharmakologie and Toxikologie, Universitatsspital Basel
    Praxis (Bern 1994) 96:1293-7. 2007
  29. doi request reprint Safety of non-therapeutic atomoxetine exposures--a national poison data system study
    Andrew A Monte
    University of Colorado Denver School of Medicine, Aurora, Colorado, USA Rocky Mountain Poison and Drug Center, Denver, Colorado, USA
    Hum Psychopharmacol 28:471-6. 2013
    ..This study's objective is to assess the safety of non-therapeutic atomoxetine exposures reported to the US National Poison Database System (NPDS)...
  30. doi request reprint Case-control analysis on metformin and cancer of the esophagus
    Claudia Becker
    Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, Basel University Hospital, University of Basel, Spitalstrasse 26, 4031, Basel, Switzerland
    Cancer Causes Control 24:1763-70. 2013
    ..Metformin use has been associated with decreased cancer risks, though data on esophageal cancer are scarce. We explored the relation between use of metformin or other anti-diabetic drugs and the risk of esophageal cancer...
  31. doi request reprint Pharmacokinetics and metabolism of idebenone in healthy male subjects
    Michael Bodmer
    Department of Clinical Pharmacology, University Hospital Basel, Basel, Switzerland
    Eur J Clin Pharmacol 65:493-501. 2009
    ..Since in previous pharmacokinetic trials only lower doses were studied, it was the aim of this study to evaluate the pharmacokinetics of idebenone in higher doses of up to 2,250 mg/day...
  32. pmc Effect of therapeutic doses of acetaminophen (up to 4 g/day) on serum alanine aminotransferase levels in subjects consuming ethanol: systematic review and meta-analysis of randomized controlled trials
    Barry Rumack
    Denver Health and Hospital Authority Rocky Mountain Poison and Drug Center, Denver, Colorado 80204, USA
    Pharmacotherapy 32:784-91. 2012
    ..To quantify the effect of therapeutic doses of acetaminophen on serum alanine aminotransferase (ALT) levels in subjects who consumed ethanol...
  33. doi request reprint Heat exposure of Cannabis sativa extracts affects the pharmacokinetic and metabolic profile in healthy male subjects
    Martin Eichler
    Departments of Clinical Pharmacology and Gastroenterology and Hepatology, University Hospital Basel, Petersgraben 4, Basel, Switzerland
    Planta Med 78:686-91. 2012
    ..These results indicate that use of unheated extracts may lead to a beneficial change in metabolic pattern and possibly better tolerability...
  34. doi request reprint Low-molecular-weight heparin overdose: management by observation
    Andrew A Monte
    Rocky Mountain Poison and Drug Center, University of Colorado Denver, USA
    Ann Pharmacother 44:1836-9. 2010
    ..To describe 3 episodes of low-molecular-weight heparin (LMWH) overdose in 2 patients and discuss the clinical presentations, outcomes, and therapeutic options...
  35. pmc Dextromethorphan, chlorphenamine and serotonin toxicity: case report and systematic literature review
    Andrew A Monte
    Rocky Mountain Poison and Drug Center, Denver University of Colorado Denver School of Medicine, Aurora, USA
    Br J Clin Pharmacol 70:794-8. 2010
    ..Chlorphenamine is a serotonergic medication and combinations of chlorphenamine and dextromethorphan may be dangerous in overdose due to an increased risk of serotonin toxicity...
  36. ncbi request reprint Acute liver failure in two patients with regular alcohol consumption ingesting paracetamol at therapeutic dosage
    Stephan Krahenbuhl
    Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland
    Digestion 75:232-7. 2007
    ..The possible role of alcohol in the development of hepatotoxicity associated with therapeutic doses of paracetamol (acetaminophen) is currently debated...
  37. doi request reprint Diuretic use, RAAS blockade and morbidity in elderly patients presenting to the Emergency Department with non-specific complaints
    Juliane M Ruedinger
    Department of Emergency Medicine, University Hospital Basel, Switzerland
    Swiss Med Wkly 142:w13568. 2012
    ..The hypothesis was tested that the use of diuretics and RAAS blockade could be associated with an increased incidence of serious conditions in those patients...
  38. doi request reprint Interaction between pivaloylcarnitine and L-carnitine transport into L6 cells overexpressing hOCTN2
    Liliane Todesco
    Division of Clinical Pharmacology and Toxicology and Department of Research, University Hospital, CH 4031 Basel, Switzerland
    Chem Biol Interact 180:472-7. 2009
    ..Hypocarnitinemia in such patients therefore develops due to massive renal losses of pivaloylcarnitine and not due to inhibition of carnitine reabsorption by pivaloylcarnitine...
  39. ncbi request reprint Hepatitis with fibrin-ring granulomas
    B Khanlari
    Dept Internal Medicine, University Hospital, Basel, Switzerland
    Infection 36:381-3. 2008
    ..The history revealed a travel to Malta 2 years earlier. Despite adequate treatment with liposomal amphotericin B the patient deteriorated and finally died in septic shock...
  40. doi request reprint [Intoxication with lithium]
    K Fiegler
    Departement fur Innere Medizin, Universitatsspital Basel, Basel
    Praxis (Bern 1994) 98:685-90; quiz 691-2. 2009
    ..The pharmacokinetic characteristics of lithium is described and the risk factors leading to lithium intoxication and treatment of intoxication are discussed...